GlassScriptPhysician profile
Doris Chukwu
NPI 1427631217
$2,305.45
in general payments reported to CMS, 2019-2025
7 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $407 · 2022: $122 · 2023: $1,021 · 2024: $227 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,740 · Education: $35.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,740.13 |
| Education | $35.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $849.32 | 2023-2025 | Nuplazid |
| Abbvie INC. | $538.03 | 2021-2023 | |
| Vanda Pharmaceuticals INC. | $347.45 | 2025 | Fanapt |
| Teva Pharmaceuticals USA, INC. | $233.03 | 2021-2023 | Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $156.20 | 2023-2024 | Abilify Asimtufii, Abilify Maintena, Nuedexta |
| Neurocrine Biosciences, INC. | $125.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $56.42 | 2025 | Invega Sustenna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doris Chukwu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.